Cargando…
FAAH selectively influences placebo effects
Endogenous opioid and cannabinoid systems are thought to act synergistically regulating antinociceptive and reward mechanisms. To further understand the human implications of the interaction between these two systems, we investigated the role of the common, functional missense variant Pro129Thr of t...
Autores principales: | Peciña, M., Martínez-Jauand, M., Hodgkinson, C., Stohler, C.S., Goldman, D., Zubieta, J.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222079/ https://www.ncbi.nlm.nih.gov/pubmed/24042479 http://dx.doi.org/10.1038/mp.2013.124 |
Ejemplares similares
-
Molecular Mechanisms of Placebo Responses In Humans
por: Peciña, Marta, et al.
Publicado: (2014) -
Prefrontal expectancy and reinforcement-driven antidepressant placebo effects
por: Peciña, M., et al.
Publicado: (2018) -
Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission
por: Prossin, Alan, et al.
Publicado: (2021) -
FAAH inhibitors in the limelight, but regrettably
por: Mallet, Christophe, et al.
Publicado: (2016) -
Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeys
por: Banijamali, Ali R, et al.
Publicado: (2014)